Efficacy and safety of finerenone in patients with CKD and type 2 diabetes across the frailty spectrum: a FIDELITY post hoc analysis

被引：0
|
作者：
Rossing, P. [1 ,2 ]
Birkenfeld, A. [3 ,4 ]
Fioretto, P. [5 ]
McGill, J. B. [6 ]
Anker, S. D. [7 ,8 ]
Pitt, B. [9 ]
Scalise, A. [10 ]
Scott, C. [11 ]
Filippatos, G. [12 ]
机构：
[1] Steno Diabet Ctr Copenhagen, Herlev, Denmark
[2] Univ Copenhagen, Copenhagen, Denmark
[3] Univ Clin, Tubingen, Germany
[4] German Ctr Diabet Res, Neuherberg, Germany
[5] Univ Padua, Dept Med, Padua, Italy
[6] Washington Univ, Sch Med, St Louis, MO USA
[7] Charite, Berlin, Germany
[8] Wroclaw Med Univ, Wroclaw, Poland
[9] Univ Michigan, Sch Med, Ann Arbor, MI USA
[10] Bayer Hispania SL, Barcelona, Spain
[11] Bayer PLC, Reading, Berks, England
[12] Natl & Kapodistrian Univ Athens, Athens, Greece
来源：
DIABETOLOGIA | 2024年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
892
引用
收藏
页码：S426 / S427
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of finerenone in chronic kidney disease and type 2 diabetes patients: a systematic review and meta-analysis
    Yasmin, Farah
    Aamir, Muhammad
    Najeeb, Hala
    Atif, Abdul Raafe
    Siddiqui, Abdul Hannan
    Ahsan, Muhammad Nadeem
    Moeed, Abdul
    Ali, Syed Hasan
    Tahir, Haya Muhammad
    Asghar, Muhammad Sohaib
    ANNALS OF MEDICINE AND SURGERY, 2023, 85 (10): : 4973 - 4980
  • [22] Hypokalaemia in patients with type 2 diabetes and chronic kidney disease: the effect of finerenone-a FIDELITY analysis
    Pitt, Bertram
    Agarwal, Rajiv
    Anker, Stefan D.
    Rossing, Peter
    Ruilope, Luis
    Herzog, Charles A.
    Greenberg, Barry
    Pecoits-Filho, Roberto
    Lambelet, Marc
    Lawatscheck, Robert
    Scalise, Andrea
    Filippatos, Gerasimos
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2024, 11 (01) : 10 - 19
  • [23] Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysis
    Perakakis, Nikolaos
    Bornstein, Stefan R.
    Birkenfeld, Andreas L.
    Linkermann, Andreas
    Demir, Muenevver
    Anker, Stefan D.
    Filippatos, Gerasimos
    Pitt, Bertram
    Rossing, Peter
    Ruilope, Luis M.
    Kolkhof, Peter
    Lawatscheck, Robert
    Scott, Charlie
    Bakris, George L.
    DIABETES OBESITY & METABOLISM, 2024, 26 (01): : 191 - 200
  • [24] Effect of finerenone on the incidence of hypokalemia in patients with type 2 diabetes and chronic kidney disease: A FIDELITY analysis
    Pitt, B.
    Agarwal, R.
    Anker, S.
    Bakris, G.
    Rossing, P.
    Ruilope, L.
    Herzog, C.
    Greenberg, B.
    Pecoits-Filho, R.
    Zannad, F.
    Lambelet, M.
    Lawatscheck, R.
    Scalise, A.
    Filippatos, G.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 415 - 415
  • [25] Efficacy and safety of finerenone by age and sex subgroups in patients with chronic kidney disease and type 2 diabetes
    Bansal, S.
    Anker, S.
    Bakris, G.
    Filippatos, G.
    Rossing, P.
    Ruilope, L.
    Birne, R.
    Canziani, M.
    Farjat, A.
    Brinker, M.
    Pitt, B.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 197
  • [26] Efficacy and Safety of Finerenone in Patients with CKD and T2D by Baseline Insulin Treatment
    Rossing, Peter
    Agarwal, Rajiv
    Anker, Stefan
    Filippatos, Gerasimos
    Pitt, Bertram
    Ruilope, Luis M.
    Macisaac, Richard
    Wainstein, Julio
    Joseph, Amer
    Roessig, Lothar
    Scott, Charlie
    Bakris, George
    DIABETES, 2021, 70
  • [27] Cardiorenal Outcomes with Finerenone in Asian Patients with Chronic Kidney Disease and Type 2 Diabetes: A FIDELIO-DKD post hoc Analysis
    Koya, Daisuke
    Anker, Stefan D.
    Ruilope, Luis M.
    Rossing, Peter
    Liu, Zhihong
    Lee, Byung Wan
    Lee, Chien-Te
    Scott, Charlie
    Kolkhof, Peter
    Lawatscheck, Robert
    Wang, Lili
    Joseph, Amer
    Pitt, Bertram
    AMERICAN JOURNAL OF NEPHROLOGY, 2023, 54 (9-10) : 370 - 378
  • [28] Efficacy and safety of semaglutide in subjects with type 2 diabetes by race and ethnicity: a post hoc analysis of the SUSTAIN trials
    Desouza, C.
    Garg, S.
    Cariou, B.
    Furberg, J. K.
    Navarria, A.
    Nayak, G.
    Fonseca, V.
    DIABETOLOGIA, 2018, 61 : S369 - S370
  • [29] Efficacy and safety of semaglutide in elderly subjects with type 2 diabetes: a post hoc analysis of the SUSTAIN 7 trial
    Aroda, V. R.
    Sugimoto, D.
    Trachtenbarg, D.
    Warren, M.
    Navarria, A.
    Nayak, G.
    Nielsen, M. Abildlund
    Woo, V.
    DIABETOLOGIA, 2018, 61 : S367 - S367
  • [30] Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients With Type 2 Diabetes and CKD: A Post Hoc Analysis of CREDENCE Trial
    Koshino, Akihiko
    Neuen, Brendon L.
    Oshima, Megumi
    Toyama, Tadashi
    Hara, Akinori
    Arnott, Clare
    Neal, Bruce
    Jardine, Meg
    Badve, Sunil, V
    Mahaffey, Kenneth W.
    Pollock, Carol
    Hansen, Michael K.
    Wada, Takashi
    Heerspink, Hiddo J. L.
    KIDNEY INTERNATIONAL REPORTS, 2024, 9 (02): : 347 - 355
12345